← Leaderboards
Thomas Joseph Kelly
University Of Arkansas Med Scis Ltl Rock
$880,595
Attributed
$1,136,837
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $194.4K · FY2016–23$200K$150K$100K$50K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,136,837 · 3
By mechanism
R25$780,354 · 2
R21$356,483 · 1
Top collaborators
- Post Steven2 shared
- Richard Nicholas Jr1 shared
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Shmuel Yaccoby$3,520,012
- Geoffrey A Goldsmith$1,013,218
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResearch PersonnelBaseClinical TrialsClinical PracticeClinical ResearchAffectCellular BiologyAntineoplastic ProtocolsArkansasCareer ChoiceBasic ScienceBehavioral ResearchAnticancer ResearchActive LearningBiomedical ResearchCancer BiologyCause Of DeathCancer RehabilitationCancer Research ProjectCancer TherapyCareerCaringClinic
Grant awards (7)
Partnership in Cancer Research (PCAR)$77,532
R25 · FY2023 · CA · contact PI
Partnership in Cancer Research (PCAR)$156,001
R25 · FY2022 · CA · contact PI
Partnership in Cancer Research (PCAR)$156,001
R25 · FY2021 · CA · contact PI
Partnership in Cancer Research (PCAR)$156,001
R25 · FY2020 · CA · contact PI
Fibroblast-macrophage interactions induce a tumor-promoting microenvironment$162,038
R21 · FY2017 · CA
Fibroblast-macrophage interactions induce a tumor-promoting microenvironment$194,445
R21 · FY2016 · CA
STUDENT PARTNERS IN CANCER RESEARCH AND EDUCATION$234,819
R25 · FY2004 · CA